124 related articles for article (PubMed ID: 12649798)
21. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
22. Apparent anaphylaxis associated with pantoprazole.
Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
[No Abstract] [Full Text] [Related]
23. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S
Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489
[TBL] [Abstract][Full Text] [Related]
24. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.
Tolia V; Bishop PR; Tsou VM; Gremse D; Soffer EF; Comer GM;
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):384-91. PubMed ID: 16641576
[TBL] [Abstract][Full Text] [Related]
25. Adverse reactions to pantoprazole.
Ricciardi L; Fedele R; Mazzeo L; Saitta S; Mancuso V; Isola S
Scand J Gastroenterol; 2003 Jul; 38(7):800. PubMed ID: 12889570
[No Abstract] [Full Text] [Related]
26. Nonallergic anaphylaxis to pantoprazole.
Kaatz M; Bauer A; Hipler C; Elsner P
Allergy; 2002 Feb; 57(2):184. PubMed ID: 11929432
[TBL] [Abstract][Full Text] [Related]
27. Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice.
Armstrong D; Kazim F; Gervais M; Pyzyk M
Can J Gastroenterol; 2002 Jul; 16(7):439-50. PubMed ID: 12177723
[TBL] [Abstract][Full Text] [Related]
28. Pantoprazole-induced recurrent anaphylactic shock.
Fardet L; Izzedine H; Ciroldi M; Tiev KP; Cabane J
Am J Gastroenterol; 2002 Nov; 97(11):2933. PubMed ID: 12425583
[No Abstract] [Full Text] [Related]
29. [When sour does not make merry at all . Fast relief for patients with reflux].
MMW Fortschr Med; 2003 Apr; 145(15):64. PubMed ID: 15104274
[No Abstract] [Full Text] [Related]
30. Acute interstitial nephritis due to pantoprazole.
Ra A; Tobe SW
Ann Pharmacother; 2004 Jan; 38(1):41-5. PubMed ID: 14742791
[TBL] [Abstract][Full Text] [Related]
31. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
[TBL] [Abstract][Full Text] [Related]
32. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
[No Abstract] [Full Text] [Related]
33. Switching between intravenous and oral pantoprazole.
Pisegna JR
J Clin Gastroenterol; 2001 Jan; 32(1):27-32. PubMed ID: 11154164
[TBL] [Abstract][Full Text] [Related]
34. Pantoprazole-induced acute interstitial nephritis.
Moore I; Sayer JA; Nayar A; Ahmed S; Tapson JS
J Nephrol; 2004; 17(4):580-1. PubMed ID: 15372423
[TBL] [Abstract][Full Text] [Related]
35. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
Martin RM; Dunn NR; Freemantle S; Shakir S
Br J Clin Pharmacol; 2000 Oct; 50(4):366-72. PubMed ID: 11012560
[TBL] [Abstract][Full Text] [Related]
36. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
Vcev A; Begić I; Ostojić R; Jurcić D; Bozić D; Soldo I; Gmajnić R; Kondza G; Khaznadar E; Mićunović N
Coll Antropol; 2006 Sep; 30(3):519-22. PubMed ID: 17058517
[TBL] [Abstract][Full Text] [Related]
37. Protonix. First i.v. proton pump inhibitor approved.
Nursing; 2002 Feb; 32(2):18, 20. PubMed ID: 11924161
[No Abstract] [Full Text] [Related]
38. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
[No Abstract] [Full Text] [Related]
39. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
Metz DC; Pratha V; Martin P; Paul J; Maton PN; Lew E; Pisegna JR
Am J Gastroenterol; 2000 Mar; 95(3):626-33. PubMed ID: 10710049
[TBL] [Abstract][Full Text] [Related]
40. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
